Advertisement
Advertisement
Incruse Ellipta

Incruse Ellipta Overdosage

umeclidinium bromide

Manufacturer:

GlaxoSmithKline

Distributor:

Zuellig
/
Agencia Lei Va Hong
Full Prescribing Info
Overdosage
An overdose of INCRUSE will likely produce signs and symptoms consistent with the known inhaled muscarinic antagonist adverse effects (e.g. dry mouth, visual accommodation disturbances and tachycardia).
If overdose occurs, the patient should be treated supportively with appropriate monitoring as necessary.
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement